DK131887A - 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler - Google Patents

1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler

Info

Publication number
DK131887A
DK131887A DK131887A DK131887A DK131887A DK 131887 A DK131887 A DK 131887A DK 131887 A DK131887 A DK 131887A DK 131887 A DK131887 A DK 131887A DK 131887 A DK131887 A DK 131887A
Authority
DK
Denmark
Prior art keywords
pyrimidencarboxylic
thioxo
carbamoyl
tetrahydro
medicines
Prior art date
Application number
DK131887A
Other languages
English (en)
Other versions
DK131887D0 (da
DK169031B1 (da
Inventor
Karneil Singh Atwal
George Charles Rovnyak
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/008,037 external-priority patent/US4855301A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK131887D0 publication Critical patent/DK131887D0/da
Publication of DK131887A publication Critical patent/DK131887A/da
Application granted granted Critical
Publication of DK169031B1 publication Critical patent/DK169031B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK131887A 1986-03-14 1987-03-13 1,2,3,4-Tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og farmaceutiske præparater indeholdende sådanne DK169031B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US83976786A 1986-03-14 1986-03-14
US83976786 1986-03-14
US91734986A 1986-10-09 1986-10-09
US91734986 1986-10-09
US803787 1987-02-09
US07/008,037 US4855301A (en) 1986-10-09 1987-02-09 1,2,3,4-Tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters

Publications (3)

Publication Number Publication Date
DK131887D0 DK131887D0 (da) 1987-03-13
DK131887A true DK131887A (da) 1987-09-15
DK169031B1 DK169031B1 (da) 1994-08-01

Family

ID=27358497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131887A DK169031B1 (da) 1986-03-14 1987-03-13 1,2,3,4-Tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og farmaceutiske præparater indeholdende sådanne

Country Status (17)

Country Link
EP (1) EP0237347B1 (da)
JP (1) JPH0819113B2 (da)
KR (1) KR900005014B1 (da)
CA (1) CA1337655C (da)
DE (1) DE3770661D1 (da)
DK (1) DK169031B1 (da)
ES (1) ES2039234T3 (da)
FI (1) FI96683C (da)
GR (1) GR3002715T3 (da)
HU (1) HU206091B (da)
IE (1) IE60114B1 (da)
IL (1) IL81800A0 (da)
NO (1) NO871044L (da)
PH (1) PH27052A (da)
PL (1) PL153727B1 (da)
PT (1) PT84479B (da)
SU (1) SU1713437A3 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62267272A (ja) * 1986-05-15 1987-11-19 Sanwa Kagaku Kenkyusho Co Ltd 新規なジヒドロピリミジン化合物及びその塩、これらの製法並びに該化合物を有効成分とする循環器系作用剤
US4847379A (en) * 1987-11-30 1989-07-11 E. R. Squibb & Sons, Inc. 3,6-dihydro-1,5(2H)-pyrimidinecarboxylic acid esters
CN1173132A (zh) 1994-11-16 1998-02-11 辛纳普蒂克制药公司 二氢嘧啶类化合物及其用途
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
JP2000500470A (ja) * 1995-11-16 2000-01-18 シナプティック・ファーマスーティカル・コーポレーション ジヒドロピリミジンおよびその使用
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
EP0986553A4 (en) * 1997-02-04 2000-12-27 Bristol Myers Squibb Co DIHYDROPYRIMIDONE DERIVATIVES AS NPY ANTAGONISTS
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
EP1193259A4 (en) * 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
CA2498282C (en) * 2002-09-12 2012-07-10 Diakron Pharmaceuticals, Inc. Calcium channel blockers
US7157461B2 (en) 2003-07-23 2007-01-02 Bristol-Myers Squibb Co. Substituted dihydropyrimidine inhibitors of calcium channel function
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214778A (ja) * 1984-03-08 1985-10-28 Suntory Ltd Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
HUT42077A (en) * 1985-06-03 1987-06-29 Squibb & Sons Inc Process for producing diesters of 2-tioxo- or 2-oxo-pyrimidine-1,5-dicarboxylic acid and 1-acyl-pyrimidine-5-carboxylic acids and esters
US4675321A (en) * 1986-02-07 1987-06-23 Merck & Co., Inc. Substituted pyrimidines useful as calcium channel blockers
NZ219299A (en) * 1986-03-14 1989-01-06 Squibb & Sons Inc Pyrimidine derivatives

Also Published As

Publication number Publication date
PL264629A1 (en) 1988-07-21
KR900005014B1 (ko) 1990-07-16
PL153727B1 (en) 1991-05-31
JPS62265271A (ja) 1987-11-18
PT84479B (pt) 1990-08-31
IE870633L (en) 1987-09-14
IE60114B1 (en) 1994-06-01
EP0237347A3 (en) 1988-11-02
ES2039234T3 (es) 1993-09-16
FI96683B (fi) 1996-04-30
HU206091B (en) 1992-08-28
PT84479A (en) 1987-04-01
NO871044L (no) 1987-09-15
KR870008856A (ko) 1987-10-21
GR3002715T3 (en) 1993-01-25
HUT43832A (en) 1987-12-28
EP0237347B1 (en) 1991-06-12
PH27052A (en) 1993-02-01
FI871087A (fi) 1987-09-15
DE3770661D1 (de) 1991-07-18
DK131887D0 (da) 1987-03-13
IL81800A0 (en) 1987-10-20
FI96683C (fi) 1996-08-12
DK169031B1 (da) 1994-08-01
CA1337655C (en) 1995-11-28
JPH0819113B2 (ja) 1996-02-28
EP0237347A2 (en) 1987-09-16
FI871087A0 (fi) 1987-03-12
SU1713437A3 (ru) 1992-02-15
NO871044D0 (no) 1987-03-13

Similar Documents

Publication Publication Date Title
DK139287D0 (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
NO874632D0 (no) Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel.
DK143588D0 (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489D0 (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
DK518687A (da) Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
NO871526D0 (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
DK146786A (da) 4'-demethyl-4-epipodophyllotoxinderivater, deres fremstilling og anvendelse i laegemidler, isaer som antitumormidler
DK55088D0 (da) 3,4-dihydro-2h-benzo(b)pyraner, deres fremstilling og anvendelse som laegemidler
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK170986D0 (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som farmaceutika samt mellemprodukterved fremstillingen
DK366888A (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK131387A (da) 1,1-disubstituerede cyclopropanderivater, deres fremstilling og anvendelse som antimykotika
DK284688A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
NO870639D0 (no) Benzimidazolderivater og deres anvendelse som fungicider.
DK587689A (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DK627684A (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK501888A (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK37787D0 (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
DK278290D0 (da) Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler
DK527886A (da) 2,3,4,6-tetrasubstituerede 1,4-dihydropyridin-5-carboxylsyrederivater samt deres fremstilling og anvendelse
DK14885A (da) 1,4-dihydropyrazin, deres fremstilling og anvendelse som laegemidler

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PBP Patent lapsed